Randomized phase II study of abiraterone acetate maintenance in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC): ABIDO SOGUG trial
Fecha de publicación
2014Título de revista
Journal Of Clinical Oncology
Tipo de contenido
Publicación de congreso